Literature DB >> 28281138

CORR ® Tumor Board: Is There Benefit to Free Over Pedicled Vascularized Grafts in Augmenting Tibial Intercalary Allograft Constructs?

Megan E Anderson1, Jim S Wu2, Sara O Vargas3.   

Abstract

Mesh：

Year:  2017        PMID： 28281138      PMCID： PMC5384944          DOI： 10.1007/s11999-017-5312-y

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  5 in total

1.  The results of transplantation of intercalary allografts after resection of tumors. A long-term follow-up study.

Authors:  E Ortiz-Cruz; M C Gebhardt; L C Jennings; D S Springfield; H J Mankin
Journal:  J Bone Joint Surg Am       Date:  1997-01       Impact factor: 5.284

2.  Clinical and functional outcomes of tibial intercalary allografts after tumor resection.

Authors:  Germán L Farfalli; Luis Aponte-Tinao; Lucas Lopez-Millán; Miguel A Ayerza; D Luis Muscolo
Journal:  Orthopedics       Date:  2012-03-07       Impact factor: 1.390

3.  Intercalary allograft reconstructions following resection of primary bone tumors: a nationwide multicenter study.

Authors:  M P A Bus; P D S Dijkstra; M A J van de Sande; A H M Taminiau; H W B Schreuder; P C Jutte; I C M van der Geest; G R Schaap; J A M Bramer
Journal:  J Bone Joint Surg Am       Date:  2014-02-19       Impact factor: 5.284

4.  Vascularised fibula graft inlaid in a massive bone allograft: considerations on the bio-mechanical behaviour of the combined graft in segmental bone reconstructions after sarcoma resection.

Authors:  Massimo Ceruso; Fulvia Taddei; Prospero Bigazzi; Marco Manfrini
Journal:  Injury       Date:  2008-08-15       Impact factor: 2.586

5.  Imaging of vascularized fibula autograft placed inside a massive allograft in reconstruction of lower limb bone tumors.

Authors:  Marco Manfrini; Daniel Vanel; Massimiliano De Paolis; Cristina Malaguti; Marco Innocenti; Massimo Ceruso; Rodolfo Capanna; Mario Mercuri
Journal:  AJR Am J Roentgenol       Date:  2004-04       Impact factor: 3.959
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.